ADVFN US – Market Content Editor
-

Musk and Altman Clash Again as AI Leaders Accuse Each Other of Platform Manipulation
The ongoing public feud between tech CEOs Elon Musk and Sam Altman flared up once more Tuesday, as both exchanged sharp accusations over alleged algorithmic manipulation on their platforms. The conflict reignited Monday when Musk accused Apple (NASDAQ:AAPL) of favoring OpenAI’s ChatGPT over his own AI chatbot Grok on the App Store, branding it an…
-

Amphastar Shares Climb on Exclusive Licensing Deal for Three Peptide Therapies
Amphastar Pharmaceuticals (NASDAQ:AMPH) saw its stock rise 5.6% after securing an exclusive licensing agreement with Nanjing Anji Biotechnology for three proprietary peptide-based therapies aimed at oncology and ophthalmology markets. Under the deal, Amphastar gains exclusive rights to develop, produce, and market the therapies in the United States and Canada. The first candidate is an endogenous…
-

180 Life Sciences Stock Surges 75% Following Disclosure of Large Ethereum Holdings
180 Life Sciences Corp. (NASDAQ:ATNF), now operating under the name ETHZilla, experienced a sharp 75% increase in its stock price after announcing it holds 82,186 Ethereum tokens valued at roughly $349 million. The company revealed it acquired this sizable ETH position at an average cost of $3,806.71 per token. Alongside its cryptocurrency assets, ETHZilla also…
-

Trinity Biotech Shares Jump 4.4% After Successful Calibration-Free CGM Trial
Trinity Biotech plc (NASDAQ:TRIB) saw its stock increase by 4.4% following the announcement of promising clinical trial outcomes for its next-generation continuous glucose monitoring (CGM) system. The biotech firm revealed that its newly engineered needle-free glucose sensor provided precise glucose measurements over a full 15-day wear period without the need for finger-stick calibration. This breakthrough…
-

ProPhase Labs Shares Surge 38% Following Patent Approval for Esophageal Disease Test
ProPhase Labs Inc (NASDAQ:PRPH) saw its stock jump 38% after securing a crucial patent for its biomarker-based system that evaluates progression risk in Barrett’s esophagus and esophageal adenocarcinoma. The United States Patent and Trademark Office granted U.S. Patent No. 12379378-B2 for the proprietary methods supporting ProPhase’s BE-Smart™ molecular diagnostic test. This milestone follows the company’s…
-

Sinclair Shares Jump 20% Amid Strategic Review of Broadcast Unit
Shares of Sinclair, Inc. (NASDAQ:SBGI) surged 20% following the announcement of a broad strategic review targeting its broadcast business, indicating possible moves toward consolidation within the industry. The company’s board has unanimously approved an assessment to explore opportunities that could enhance shareholder value, including potential acquisitions, partnerships, or mergers with other players in the broadcast,…
-

USA Rare Earth Jumps 20% on Magnet Supply Deal with Enduro Pipeline Services
USA Rare Earth, Inc. (NASDAQ:USAR) shares climbed 20% after the company revealed it had signed a memorandum of understanding (MOU) with Enduro Pipeline Services to provide U.S.-manufactured neodymium magnets for pipeline cleaning equipment. Per the agreement, USA Rare Earth will supply magnets for Enduro’s “intelligent pigs” — specialized tools that clean and inspect pipelines using…
-

AAR Corp Buys Aerostrat in $15 Million Deal to Boost Aviation Software Portfolio
AAR CORP. (NYSE:AIR), a leader in aviation services, has purchased Aerostrat, a specialist in long-range maintenance planning software, for $15 million, with the potential for an additional $5 million in contingent payments. The move strengthens AAR’s digital solutions portfolio and enhances the enterprise resource planning (ERP) capabilities of its Trax subsidiary. Aerostrat’s signature product, Aerros,…
-

BlackSky Shares Gain on New Two-Year Gen-3 Agreement
BlackSky Technology Inc. (NYSE:BKSY) saw its shares rise 5% after revealing it had signed a two-year Gen-3 early access deal with a new international client. The customer had first engaged with the company through a Gen-2 On-Demand contract in January, marking a quick escalation in their partnership. The agreement underscores heightened interest in BlackSky’s integrated…
-

Tesla Reassigns Engineering Teams After Shutting Down Dojo AI Project – Bloomberg
Tesla Inc. (NASDAQ:TSLA) has redistributed its engineering workforce across various departments after CEO Elon Musk decided to halt the company’s in-house chip and supercomputer initiative, known as Dojo. According to Bloomberg, citing sources familiar with the matter, the disbanded Dojo team has been divided, with staff integrated into multiple units within the electric vehicle manufacturer.…